News
Company news 
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
Company news 
Oxford Nanopore Technologies and Mahidol University launch first Centre of Excellence in Southeast Asia | Oxford Nanopore Technologies
Company news 
Oxford Nanopore launches a comprehensive Hereditary Cancer Panel
Company news 
Oxford Nanopore, Yemaachi Biotech, and Global Partners Collaborate to Improve Childhood Leukemia Outcomes in Ghana
Company news 
Oxford Nanopore announces landmark UK Government partnership to advance genomics-driven healthcare innovation in the UK | Oxford Nanopore Technologies
Community news 
Two new papers further demonstrate the role adaptive sampling could play in understanding genetic disease
Company news 
Structural variation & cancer: top 7 things to read right now
Company news 
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
Company news 
Oxford Nanopore and 4bases announce collaboration to combine nanopore sequencing devices and 4bases kits to support rapid, high-accuracy analyses in human and cancer genetics
Company news 
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
Interviews 
Interview: Using PromethION for Cancer, Collaborations and more
Company news 
Interview: Tumoroids from colon cancer, including WGS-strategy
Company news 
Interview: Resolving complex genomic structures and regulation patterns in cervical cancer
Company news 
Interview: Rapid leukemia classification using nanopore sequencing
Company news 
Interview: Parent-of-origin genome analysis presents the potential to improve future genetic testing
Company news 
Interview: Optimisation and validation of a nanopore-based sequencing method for potential molecular testing of CNS tumours
Company news 
Interview: Investigating epigenomic alterations in cancer with nanopore sequencing
Company news 
Interview: Improving structural variant interpretation for hereditary cancer susceptibility
Company news 
Interview: Detecting, classifying, and monitoring CNS tumors with nanopore sequencing
Community news 
Epigenetics, Cas9-mediated enrichment and novel insights in transcriptome variation: catch up on talks from ASHG 2020